glp 1 drugs and lupus for GLP-1 Receptor Agonists Reduce Cardiovascular Kidney Risks in Lupus Patients with Type 2 Diabetes: Study glp 1 for lupus Exploring

A recent study in Nature Metabolism found people lost about 6 pounds in 8 weeks just by adding resistant starch

Zepbound Vials is the newest FDA-approved weight loss injection, featuring a dual-action formula that activates both GIP and GLP-1 receptors

Ive seen it firsthand: patients lose a significant amount of weight, then stop the medication about a year in

McGraw-Hill / Lange Rivera FB et al (2024): Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials

One study reported that GLP-1 is negatively correlated with body mass index (BMI) and that it appears to increase dentate gyrus neurogenesis based on immunostaining images (Weina et al., 2018)

Dipeptidyl peptidase-4: a key player in chronic liver disease